FindTrial
Sign In

Unani Herbal tablets for mild cases od Covid 19

A clinical study to evaluate the efficacy of tablet of Aloe Vera gel (Aloe barbadenesis),Mur Makki (Commiphora myrrha) and Sanna-e-Makki (Senna Alexandrina) in the management of mild cases of confirmed Covid -19

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/07/026669
Enrollment
60
Registered
2020-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Tablet of of Aloe Vera gel (Aloe barbadenesis),Mur Makki (Commiphora myrrha) and Sanna-e-Makki (Senna Alexandrina): Mur Makki (Commiphora myrrha), Aloe Vera gel (Aloe barbadenesis) and

Sponsors

Z V M Unani Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients of mild cases of confirmed Covid-19. Fever above 1000 F Sore throat Dry cough Breathlessness Severe body ache SPO2 saturation above 92

Exclusion criteria

Exclusion criteria: Patients in whom fever does not subside or increase in fever, SPO2 goes below 92.Increase in Breathlessness, then such patients will be excluded from the study. Immune- compromised patients. Patient having Ischemic heart disease

Design outcomes

Primary

MeasureTime frame
Improvement in Oxygen saturation of patients and decrease in temperatureTimepoint: SPO2 and temperature will be assessed daily twice from 0 day to 14 day—

Secondary

MeasureTime frame
Pocket friendly effective medicine will be availableTimepoint: 14 days—

Countries

India

Contacts

Public ContactDr Shaikh Nikhat

Z V M Unani Medical College and Hospital

jalishmd@yahoo.co.in09850541686

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026